March 23, 2017 2:46 AM ET

Company Overview of Steba Biotech S.A.

Company Overview

,  

Luxembourg

Key Executives for Steba Biotech S.A.

Steba Biotech S.A. does not have any Key Executives recorded.

Steba Biotech S.A. Key Developments

Steba Biotech Completes Its European Phase 3 Clinical Trial of TOOKAD in Patients with Low-Risk Prostate Cancer and Submits Marketing Authorization Application to the European Medicine Agency

Steba Biotech announced completion of PCM301, its European Phase 3 clinical trial of TOOKAD (padeliporfin di-potassium), a novel investigational treatment for localized prostate cancer and other solid tumors. PCM301 is the first prospective randomized controlled trial evaluating the efficacy and safety of a focal therapy in prostate cancer. The data will be presented at the upcoming European Association of Urology scientific meeting in March.

Similar Private Companies By Industry

Company Name Region
"Henderson International Select Fund SICAV Europe
12 E Rue Guillaume Kroll Europe
1590 Alternative Investments S.A Europe
1964 SICAV-SIF Syrio GLT Europe
1stamg S A Europe

Recent Private Companies Transactions

Type
Date
Target
No transactions available in the past 12 months.
 

The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
NYC2012, Inc. United States
Bertelsmann AG Europe
Rush University United States
The Advertising Council, Inc. United States

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact Steba Biotech S.A., please visit --. Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.